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Changes in penile hemodynamics after 
intracavernous injection of Prostaglandin E x 
and Prostaglandin I2 in pigtailed monkeys 
R U U D J . L . H . B O S C H , FRANCOIS B E N A R D M D , 
SHERIF R . ABOSEIF M D , CHRISTIAN G . STIEF M D , 
W A L T E R STACKL M D , T O M F . L U E M D A N D E M I L A . T A N A G H O 
Department of Urology, University of California School of Mediane, 
San Francisco, California, USA. 
We investigated the hemodynamic changes induced by intracavernous injection of 
5, 10 and 20 fxg of Prostaglandin I2 (PGI2) in 11 monkeys. 
Cavernous arterial blood flow increased for a mean duration of 20 min after 
intracavernous injection of 20 (xg PGE], as detected by ultrasound and pulsed 
Doppler studies. The degree and duration of cavernous smooth muscle relaxation 
after PGE] injection was dose-dependent, as demonstrated in cavernous perfusion 
studies. Venous occlusion occurred in only four of 11 monkeys with doses up to 
20 fjug PGEj. 
After intracavernous injection of PGt 2 no increase in cavernous arterial blood 
flow could be detected by ultrasound and pulsed Doppler studies. There was a 
large reduction of the cavernosal compliance owing to smooth muscle contraction 
with PGI 2 doses of 100 and 200 jig. 
PGI 2 / in contrast to PGE|, does not apear to be beneficial in the diagnosis and 
treatment of impotence. 
Keywords: penis, hemodynamics, injection, Prostaglandin, monkeys. 
The attainment of a füll erection depends upon three hemodynamic phenomena: 
increased flow in the cavernous arteries; cavernous smooth muscle relaxation, and 
venous outflow restriction 1 . The ability of vasoactive drugs to induce erection 
depends upon the ability of these agents to induce relaxation of cavernous and 
arterial smooth muscle cells. Various drugs, including papaverine 2, the alpha-blocker 
phenoxybenzamine 3, and vasoactive intestinal Polypeptide 4 , have been shown to 
possess this ability. The intracavernous injection of papaverine or of a combination 
of papaverine and the alpha-blocker phentolamine has gained widespread 
acceptance in the treatment of impotence 3 " 8 . However, side-effects such as 
p r i a p i s m 5 , 9 , fibrous plaque formation , hypotension, dizziness and facial flushing, 
and the destruction of normal cavernous architecture after prolonged use 1 1 have 
been reported. 
PGE] does not appear to elicit severe side-effects 1 1 , 1 2 , and it has been shown to be 
efficacious i n several clinical t r ia l s 1 2 " 1 5 . In-vitro, PGE] is able to relax both 
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cavernous smooth muscle Strips and Segments of the cavernous artery that have 
been contracted by noradrenaline 1 6 . In vivo, it increases blood flow in the 
cavernous artery in humans 1 7 . 
In vitro, P G I 2 relaxes cavernous arterial Segments and causes cavernous smooth 
muscle Strips to contract. Hedlund and A n d e r s s o n 1 6 suggest that it might increase 
cavernous arterial blood flow in the initial phase of erection and therefore might 
have a role in the treatment of impotence. The füll ränge of in-vivo effects of PGEj 
and P G I 2 on the penis is not yet well established. We therefore studied the 
hemodynamic effects of intracavernous injection of PGEj and P G I 2 in the monkey, 
whose penis closely resembles the human. 
M A T E R I A L S A N D M E T H O D S 
Eleven pigtailed monkeys ( M a c a c a n e m e s t r i n a ) , all less than 10 years old and 
weighing 4.5-7.5 kg, were used to study the changes in penile hemodynamics after 
intracavernous injection of PGE] (Upjohn) or P G I 2 (Upjohn). For all experiments 
the chosen doses of P G E , (5, 10 or 20 fxg) or P G I 2 (100 or 200 u.g) were diluted 
in 1 ml of normal saline. Dilutions were freshly prepared for each experiment. 
Four sets of experiments were performed, as follows. 
(1) Intracavernous drug injection, with recording of the intracavernous pressure 
before and after delivery. 
(2) Saline perfusion of the corpora cavernosa at a fixed rate before and after 
intracavernous drug injection 1 8 . Differences in the plateau pressure attained 
before and after reflect drug-induced changes in cavernous compliance. 
(3) Pulsed Doppler ultrasound studies of cavernous arterial flow. 
(4) Controlled infusion of saline into the cavernous bodies during periods of 
intermittent clamping of the aorta to study venous occlusion. 
O w i n g to the limited availability of the monkeys used, it was not the intention of 
this investigation to represent a complete dose-response study. 
EXPERIMENT 1 
After anesthesia with ketamine (30 mg/kg body weight, IM), the monkeys were 
placed in the supine position. Under sterile conditions a 21-gauge scalp-vein 
needle was placed in the distal part of each cavernous body away from the vestigial 
penile bone. One needle was connected to a Statham transducer (model P23 BC) 
and used for recording the intracavernous pressure on a Grass Polygraph (Model 
7). The other needle was used for intracavernous injection or saline perfusion. 
Penile tumescence was observed visually and noted in relation to the pressure 
changes. Injections with each dose of P G E X or P G I 2 were given twice on separate 
occasions (except for monkeys 9, 10 and 11 who received only one 20-/xg dose of 
P G E i during an acute experiment). The penis was not massaged i n order not to 
disturb the carefully placed intracavernous needles. 
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FIGURE 1. Perfusion protocol: A baseline measurement ("control perfusion") during saline 
perfusion at 11.5 ml/min is first obtained, and the drug is then injected intracavernously. 
Measurement is repeated at 2— to 5—min intervals until the plateau pressure has returned 
to the baseline value. 
E X P E R I M E N T 2 
Perfusion protocol (see Figure 1). Saline was perfused at the rate of 11.5 ml/min 
for about 1 min (Harvard perfusion pump) and the plateau pressure was recorded. 
In preliminary studies this perfusion rate led to only minimal penile elongation 
and a baseline plateau pressure of about 60 cm H 2 0 in most monkeys. It proved 
to be a convenient rate for comparison of plateau pressures before and after 
pharmacologic manipulations. 
After the above measurement, perfusion at the same rate and for the same 
duration was repeated within 2 min after intracavernous injection of a drug. The 
resulting plateau pressure was compared with the baseline plateau. To measure 
the duration of the drug's action, subsequent saline perfusions of the same rate 
and duration were repeated at regulär intervals without further drug injection. The 
end of the drug's action was defined as that point at which the plateau pressure 
returned to baseline. It is possible, however, that the repeated perfusions washed 
out the drug and thereby decreased the apparent duration of action. Doses of 5 
ixg (n = 4), 10 u.g (n = 8) or 20 |xg (n = 5) of PGE] and 100 u.g (n = 4) or 200 
|xg (n = 6) of P G I 2 were tested. Each dose was given twice. The second trial was 
performed after the perfusion plateau had returned to its baseline value. In 
Results, the mean value of these two trials is used. 
EXPERIMENT 3 
To examine possible changes in the arterial flow, we performed pulsed Doppler 
ultrasound studies of the cavernous artery 1 9 in monkeys 1, 2, 4, 5, 6, 7 and 8 before 
and after intracavernous drug injection. The monkeys were anesthetized as before, 
and the flow velocity in the cavernous artery before and after injection of 20 u,g 
P G E i or 200 |xg P G I 2 was measured. 
EXPERIMENT 4 
Three monkeys, 9, 10 and 11, were used to study the possible occurrence of venous 
outflow restriction. With the same basic set-up as described above, the abdominal 
cavity was opened through a midline incision and the infrarenal aorta was exposed 
for intermittent clamping with a Satinsky clamp. While the aorta was clamped, the 
cavernous bodies were perfused at a rate of 11.5 ml/min before and after injection 
of 20 |xg P G E i . Because Experiments 1 and 2 had shown that P G I 2 induced penile 
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FIGURE 2. After 20 u-g P G E ] in one monkey, the intracavernous pressure rose briefly after 
the initial slight drop. In the venous occlusion study, cavernous perfusion of saline after 
clamping of the aorta led to an off-scale pressure rise after about 10 s. In subsequent 
perfusion, more time was needed to reach an off-scale pressure, reflecting the waning of 
the action of P G E i. 
shrinkage only (see Results), this experiment was performed only with P G E ] . 




In monkeys 1 through 8, intracavernous injection of 5 u,g (n = 4), 10 |xg (n = 8) 
and 20 jxg (n = 5) of P G E [ was followed by a drop in the intracavernous pressure 
TABLE 1. Pressure plateau during saline perfusion after PGE| or PGI 2*. 
PGE, PGI 2 
Monkey 5 M-g 10 fxg 20 jjLg 100 ^g 200 ü.g 
1 N.D. 50% 38% N.D. 107% 
2 28% 25% 10% N.D. 194% 
3 N.D. 54% O.S. N . D . 125% 
4 40% 35% O.S. 135% N.D. 
5 N.D. O.S. N . D . 142% N.D. 
6 N.D. 93% 87% 110% O.S. 
7 42% 37% N . D . 114% 104% 
8 O.S. O.S. N . D . N . D . 115% 
*Rate of saline perfusion = 11.5 ml/min. The plateau pressure attained with perfusion before 
drug injection = 100%. Values are means of the results of 2 trials. 
N . D . = not done. O.S. = out of scale (>180 cmH 2 0). 
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that was both brief and slight (<20 s; <15 c m H 2 0 ) . None of these monkeys 
exhibited a subsequent rise in intracavernous pressure above the pre-injection 
value, although some penile elongation was seen in all . However, monkey 9 (an 
acute study) exhibited an increase in the intracavernous pressure (see Figure 2) 
w i t h a dose of 20 jxg. 
Intracavernous injection of P G I 2 i n doses of 100 u-g (n = 4) and 200 jxg {n = 6) 
resulted in a shrinkage or a decrease in length of the penis. This made pressure 
recording very difficult as the recording needle tended to become blocked despite 
repeated flushing with heparin. This clear response seen in all monkeys suggested 
a strong contraction of the cavernous smooth muscles. 
E X P E R I M E N T 2 
In monkeys 1 through 8, the baseline plateau pressure with perfusion ranged 
between 48 and 112 c m H 2 0 . However, each animal's baseline plateau pressure 
was defined as 100%; thus, differences were due to variations in penile size and 
baseline compliance. 
P G E i RESULTS . Table 1 summarizes the percentages of the baseline plateau 
pressures reached during perfusion, about 2 min after administration of various 
doses of P G E i . Two different types of reaction were seen. 
In the first type (see Figure 3) the plateau pressure after drug administration 
was lower than the baseline plateau. This was seen in monkeys 1, 2, 6 and 7 (with 
all doses), 3 (with 10 (jig only), and 4 (with 5 and 10 jxg). In monkeys in which 
different dosages were used, the pressure was always lower with the higher dose 
(see Table 1). TheTowering of the pressure plateau was always accompanied by 
penile elongation, owing to cavernous smooth muscle relaxation and a higher 
cavernous compliance. 
The second type of response (see Figure 4) was an intracavernous pressure 
increase that was initially attenuared with respect to the baseline plateau, but 
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FIGURE 3. Example of first type of reaction (see text) before (A) and after (B) injection of 
PGE!. The plateau pressure is significantly decreased, and penile tumescence and 
elongation occur. 
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FIGURE 4. Example of the second type of reaction (see text) before (A) and after (B) PGE,. 
The plateau pressure is initially less than the baseline plateau pressure (A) and then rises 
off the scale (B), concurrent with füll penile erection. 
and 4 (with 20 |xg), 5 (with 10 fxg), and 8 (with 5 fxg and 10 fxg), always 
accompanied by füll penile rigidity. This type of reaction results from initial 
cavernous smooth muscle relaxation followed by complete venous outflow 
restriction. 
The duration of the drug's action was measured by repeated perfusions at 2- to 
5-min intervals until the plateau pressure returned to baseline. Plateau pressures 
recovered within 8-15 min (mean: 13.5 min) after the 5-jxg dose and within 17-25 
min (mean: 20 min) and 12-30 min (mean: 20.5 min) with 10 jxg and 20 jxg, 
respectively. 
P G I 2 RESULTS . Table 1 lists the plateau pressures associated with administration of 
100 jxg or 200 \xg P G I 2 . These were always higher than the baseline value. For 
example, i n monkey 6, 200 jxg P G I 2 resulted in a plateau pressure that rose off 
the scale (> 180 c m H 2 0 ) . The higher pressures after P G I 2 administration were 
invariably accompanied by penile shrinkage. 
Although repeated perfusions may/have washed out P G I 2 and might have 
decreased the duration of its action, the plateau pressure returned to baseline 
within 8-10 min (mean: 9 min) after 100 |xg and within 7-21 m i n (mean: 13 min) 
after 200 u,g. Interestingly, in four of the eight monkeys, the arterial pulsations 
that were superimposed on the cavernous pressure recording were of a larger 
amplitude after P G I 2 than before (see Fig 5). 
EXPERIMENT 3 
In monkeys 1, 2, 4, 5, 6, 7 and 8, the cavernous arteries were studied wi th pulsed 
Doppler ultrasound before and after intracavernous injection of 20 |xg P G E i and 
before and after injection of 200 [ig P G I 2 . The signal from the cavernous artery 
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2 min 4 min 
L J 
Perfusion (11.5 mi/min) 
2 min 4 min 
f ln j .PGI -2 |_ J 
( 2 0 0 "9) Perfusion (11.5 ml/min) 
FIGURE 5. Intracavernous pressure before (A) and after (B) injection of 200 jxg PGI 2. After 
injection but before the Start of saline perfusion, the intracavernous pressure increases, 
accompanied by penile shrinkage. The plateau pressure during perfusion is higher than 
before PGI2 injection, although the penis is shrunken at this time. Note also the increased 
amplitude of arterial pulsations (arrows) superimposed on the intracavernous pressure after 
PGI 2 injection. 
was not detectable in any of the seven monkeys before injection. 
PGE] RESULTS . The peak flow velocity in the cavernous artery could be measured 
after injection in six of the seven monkeys (Table 2 and Figure 6). The measurement 
was repeated periodically until no signal could be detected. The peak flow velocity 
occurred 4-28 min (mean 12.5 min) after P G E i injection. However, in any animal 
the true maximum could have been missed because the measurements were not 
continuous (relocating the cavernous artery determined the timing). The drug's 
reported duration of action on cavernous arterial flow also represents an estimate: 
we recorded the time at which a signal was detected for the last time (ranging 
between 14 and 32 min; mean 18.5 min) and the first time at which the signal could 
no longer be detected (ranging between 10 and 30 min ; mean 23.5 min). The actual 
duration of action lies between these two values. 
TABLE 2. Pulsed Doppler ultrasound of the cavernous arterial flow after 20 fxg PGEj. 
Monkey 
Peak flow velocity 
(cm/s) 
Time of maximal 
response (min)* 
Duration of 
flow increase (min) 
1 14 8 13-18 
2 15 9 10-14 
4 47 13 29-32 
5 24 4 15-20 
6 29 13 14-25 
7 24 28 30-32 
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FIGURE 6 (See opposite page). Flow velocity measurement with pulsed Doppler ultrasound 
after intracavernous injection of 20 jxg P G E ^ (A) velocity increase in the cavernous artery 
1 min after the intracavernous injection; (B) greater velocity at 5 min; (C) velocity at 9 min 
after the injection, slightly less than that at 5 min. Before P G E ! injection the cavernous artery 
was not detectable. 
P G I 2 RESULTS . A flow signal could be detected only in monkey 2 after injection of 
200 jxg P G I 2 . The maximal peak flow velocity of 15 cm/s occurred 24 min after the 
injection. The duration of the increase was between 31 and 47 min. 
E X P E R I M E N T 4 
W i t h the aorta clamped, the cavernous bodies were perfused before and after 
injection of 20 |xg P G E ! in monkeys 9, 10 and 11. Two types of reaction were seen. 
In one monkey with a baseline plateau pressure of 75 c m H 2 0 , the recording rose 
off the scale 10 s after saline infusion was begun after P G E i injection. During this 
time the penis was fully erect, owing to venous occlusion (Fig 2). In the other two 
monkeys plateau pressures decreased to 44 c m H 2 0 (from 116 c m H 2 0 ) and 46 
c m H 2 0 (from 86 c m H 2 0 ) respectively, 3 min after P G E i injection. N o changes in 
systemic blood pressure occurred in any of the three. 
DISCUSSION 
Prostaglandin E x increases cavernous arterial blood flow. The fact that ultrasound 
Signals could not be detected before injection but were easily detected after can be 
accounted for only by an increase in flow. Furthermore, intracavernous injection 
of P G E i leads to an increase in cavernous compliance (demonstrated by the change 
in plateau pressure during perfusion) owing to cavernous smooth muscle 
relaxation. The two types of responses seen with cavernous perfusion after P G E i 
injection are: a lowering of the plateau pressure from the baseline plateau; and an 
initial attenuation of the pressure increase wi th respect to the baseline plateau 
followed by a rapid increase in intracavernous pressure to off-scale levels (see 
Results). These two types of responses are not basically different, but represent a 
difference in the degree of smooth muscle relaxation. Moderate relaxation leads to 
a reaction of the first type; greater relaxation is accompanied by a closure of the 
venous drainage Channels during perfusion, resulting in an increase in pressure 
to off-scale values. The degree and duration of this relaxation appear to be dose-
dependent (eg 5 juug PGE] has a considerably shorter duration of action than 10 u,g 
or 20 |xg). This is similar to the finding of Stackl et a l . 1 2 who reported a dose-
dependent duration of action in men. 
In humans, P G E i in doses up to 20 |xg leads to a füll erection in most impotent 
p a t i e n t s 1 2 , 1 4 . In normal monkeys, however, the drug induces only some penile 
elongation, indicating only partial smooth muscle relaxation. The fact that venous 
occlusion occurred i n only some of the monkeys reflects a difference in the degree 
of relaxation among the animals. The discrepant reaction between men and 
monkeys might result from a difference in the number of P G E X receptors in the 
cavernous tissue or, perhaps more importantly, a difference in the affinity of these 
receptors for P G E i . Preliminary studies of P G E i receptors in our laboratory point 
to the importance of the latter. Furthermore, an effect of the ketamine anesthesia 
cannot be excluded. 
P G E i is a natural constiruent of many mammalian tissues 2 0, is rapidly metabolized 
after injection 2 1 , and apparently has fewer side-effects than papaverine after 
intercavernous injection It is therefore an attractive alternative to papaverine. 
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W e were u n a b l e to observe an increase i n c a v e r n o u s arterial f low after in t ra -
cavernous in jec t ion of P G I 2 . H o w e v e r , s o m e c o n s i d e r a t i o n s cast d o u b t o n the 
results of o u r p u l s e d D o p p l e r u l t r a s o u n d s tudies : an increase i n a m p l i t u d e of 
arter ia l p u l s a t i o n s w a s s u p e r i m p o s e d o n the i n t r a c a v e r n o u s p r e s s u r e r e c o r d i n g i n 
four of o u r e ight m o n k e y s ; o ther invest igators h a v e r e p o r t e d that P G I 2 resul ts i n 
re laxat ion of cavernous arter ia l Segments i n the m u s c l e b a t h 1 6 ; i n o u r s t u d y , p e n i l e 
s h r i n k a g e after i n t r a c a v e r n o u s in jec t ion m a d e m e a s u r e m e n t s p a r t i c u l a r l y d i f f icul t 
a n d p o s s i b l y u n r e l i a b l e . N e v e r t h e l e s s , w e f o u n d a n increase i n c a v e r n o u s arter ia l 
f low i n one of seven m o n k e y s . Interest ing ly , this increase d i d not result i n p e n i l e 
tumescence or erect ion , u n d e r s c o r i n g the i m p o r t a n c e of c a v e r n o u s s m o o t h m u s c l e 
re laxat ion e v e n i n the ear ly phase o f the i n d u c t i o n of e rec t ion . PGI2 a d m i n i s t r a t i o n 
d i d not result i n cavernous s m o o t h muscle relaxation. The h igher plateau pressures 
d u r i n g cavernous perfusion after P G I 2 admin i s t ra t ion were invar iably accompanied 
b y peni le s h r i n k a g e . T h e s e f i n d i n g s d e m o n s t r a t e that P G 1 2 in j ec t ion results i n 
cavernous s m o o t h m u s c l e cont rac t ion a n d a l o w e r c a v e r n o u s c o m p l i a n c e . 
A d d i t i o n a l s tudies of this drug c o u l d p r o v e to be i n t e r e s t i n g . If the effects of 
P G I 2 o n the c a v e r n o u s artery c o u l d be m e a s u r e d more re l iab ly i n v i v o , it m a y be 
poss ib le to p r o v e that arterial d i l a t i o n cannot i n d u c e an erect ion if c a v e r n o u s 
c o m p l i a n c e is not increased at the same t i m e . O u r s t u d y s h o w s that P G I 2 causes 
a decrease in c a v e r n o u s c o m p l i a n c e a n d s h r i n k a g e of the p e n i s . A s c o m p a r e d with 
the n o r m a l f laccid State, this s h r i n k a g e can be a c c o u n t e d for by increased m y o g e n i c 
tone . In the f laccid p e n i s , the tone o f the c a v e r n o u s s m o o t h m u s c l e s is m a i n t a i n e d 
b e t w e e n füll re laxat ion a n d füll c o n t r a c t i o n . H y p e r i n v o l u t i o n of the p e n i s o n the 
basis of increased m y o g e n i c tone has p r e v i o u s l y b e e n d e s c r i b e d i n the rabbit after 
t ransect ion of the s y m p a t h e t i c c h a i n s . 
In c o n c l u s i o n , w e f o u n d that P G E ] acts i n v i v o v i a c a v e r n o u s s m o o t h m u s c l e 
re laxat ion a n d an increase i n blood flow i n the c a v e r n o u s artery. T h e degree a n d 
d u r a t i o n of these effects are dose -dependent . V e n o u s o u t f l o w o b s t r u c t i o n w a s 
f o u n d o n l y i n a p p r o x i m a t e l y one t h i r d o f the m o n k e y s s t u d i e d . 
W i t h P G I 2 w e d i d not observe a n increase i n c a v e r n o u s arterial blood flow. A 
decrease i n the c a v e r n o u s c o m p l i a n c e , h o w e v e r , w a s o b v i o u s . In contrast to P G E , , 
P G I 2 appears not to be h e l p f u l i n the d i a g n o s i s a n d t reatment of i m p o t e n c e . 
A C K N O W L E D G H M E N T - Dr Bosch was the recipient of a grant from the Sophia Foundation 
for Medical Research (The Netherlands). 
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